Siemens Healthineers at SNMMI 2023
Thank you for joining us at SNMMI 2023 in Chicago.
At the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2023 annual meeting, you had the opportunity to learn about Symbia Pro.specta™ SPECT/CT, experience Biograph Vision Quadra,™ and see the newly launched Biograph Vision.X™ with advanced PET/CT scanner technology. You still have the opportunity to discover how our integrated value chain enables theranostics programs with precision oncology tools for every step of the care pathway.
Save the date for SNMMI 2024:
Date: June 8 - 11, 2024
Location: Toronto, Canada
Venue: Metro Toronto Convention Centre
Empowering precision oncology: Expanding access to next-generation theranostics
Joseph R. Osborne, MD, PhD; Chief, Division of Molecular Imaging and Therapeutics, Professor of Radiology, Weill Cornell Medicine, New York, New York.
Symbia Pro.specta: Putting the "Pro" in SPECT/CT imaging
Alex Torres, CNMT, (ARRT)(N)(CT); Natasha Befrui, BS, CNMT, (ARRT)(N)(CT); Nuclear Medicine Technologists, Department of Radiology, Houston Methodist Hospital, Houston, Texas, USA.
Highlight products and topics
Explore our highlight product and topics from SNMMI.
Come celebrate with us 10 years of game-changing innovation in molecular imaging with xSPECT and FlowMotion.
PETNET Solutions, Inc.
See our complete portfolio
Your resource for the latest news, stories, and clinical cases in nuclear medicine and molecular imaging.
We look forward to meeting you at SNMMI 2024 in Toronto, June 8-11, 2024.
The products/features mentioned herein are not commercially available in all countries. Their future availability cannot be guaranteed.
The statements by Siemens Healthineers customers described herein are based on results that were achieved in the customer's unique setting. Because there is no “typical” hospital or laboratory and many variables exist (e.g., hospital size, samples mix, case mix, level of IT and/or automation adoption) there can be no guarantee that other customers will achieve the same results.